Exploiting selective BCL-2 family inhibitors to dissect cell survival dependencies and define improved strategies for cancer therapy. (Q33421292)
Jump to navigation
Jump to search
scientific article
| Language | Label | Description | Also known as |
|---|---|---|---|
| English | Exploiting selective BCL-2 family inhibitors to dissect cell survival dependencies and define improved strategies for cancer therapy. |
scientific article |
Statements
Exploiting selective BCL-2 family inhibitors to dissect cell survival dependencies and define improved strategies for cancer therapy (English)
Joel D Leverson
Darren C Phillips
Michael J Mitten
Erwin R Boghaert
Dolores Diaz
Stephen K Tahir
Lisa D Belmont
Paul Nimmer
Yu Xiao
Xiaoju Max Ma
Kym N Lowes
Peter Kovar
Jun Chen
Sha Jin
Morey Smith
John Xue
Haichao Zhang
Anatol Oleksijew
Terrance J Magoc
Kedar S Vaidya
Daniel H Albert
Jacqueline M Tarrant
Nghi La
Le Wang
Zhi-Fu Tao
Michael D Wendt
Deepak Sampath
Saul H Rosenberg
Chris Tse
Wayne J Fairbrother
Steven W Elmore